No significant differences were found between groups in gender, race, tumor or nodal stage, distance from the AV, circumferential extent, pretreatment CEA level, pathologic differentiation, concurrent chemotherapy, or radiotherapy dose (Tables 2 and 3). The gene discussed is CEACAM5; the disease is neoplasm.